Showa Pharmaceutical University · Laboratory of Pharmaceutics

Research keywordsCTLA-4 blockade・helix-loop-helix peptides・dendritic cell immunotherapy・cytokine gene transfection・tumor immunotherapy・tumor microenvironment

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• A selective cytotoxic adenovirus vector for concentration of pluripotent stem cells in human pluripotent stem cell-derived neural progenitor cells. Hirai T, Kono K, Sawada R, Kuroda T, Yasuda S, Matsuyama S, Matsuyama A, Koizumi N, Utoguchi N, Mizuguchi H, Sato Y Sci Rep. 11 11407 20212021
• Fiber-Knob Region of Adenovirus Type 5 Vector Promotes Migration of A549 Cells. Kano J, Koizumi N, Terada A, Matsuoka A, Hirai T, Nomura T, Mizuguchi H, Utoguchi N BPB Reports 4 17-21 20212021
• The infectivity of progeny adenovirus in the presence of neutralizing antibody. Hirai T, Sato A, Koizumi N, Kurioka Y, Suzuki Y, Kano J, Yamakawa M, Nomura T, Fujii M, Sakurai F, Mizuguchi H, Watanabe Y, Utoguchi N J Gen Virol. 104 001590 20212021
• Expression of p57KIP2 reduces growth and invasion, and induces syncytialization in a human placental choriocarcinoma cell line, BeWo Takahashi K, Yoneyama Y, Koizumi N, Utoguchi N, Kanayama N, Higashi N. Placenta 104 168-178 20202020

• Official profile